{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:20:34Z","timestamp":1776338434887,"version":"3.51.2"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142448","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T18:52:41Z","timestamp":1449859961000},"page":"e0142448","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats"],"prefix":"10.1371","volume":"10","author":[{"given":"Rita","family":"Casc\u00e3o","sequence":"first","affiliation":[]},{"given":"Bruno","family":"Vidal","sequence":"additional","affiliation":[]},{"given":"In\u00eas P.","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Eunice","family":"Paisana","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Rino","sequence":"additional","affiliation":[]},{"given":"Luis F.","family":"Moita","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o E.","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.berh.2008.01.003","article-title":"Immune-mediated pathways in chronic inflammatory arthritis","volume":"22","author":"CL Gorman","year":"2008","journal-title":"Best practice & research Clinical rheumatology"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.rhu.0000130683.61892.b2","article-title":"A pathophysiologic approach to the clinical management of arthritis and pain: current and future implications","volume":"10","author":"B Hahn","year":"2004","journal-title":"Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.physbeh.2007.12.012","article-title":"The role of physical activity in rheumatoid arthritis","volume":"94","author":"G Plasqui","year":"2008","journal-title":"Physiology & behavior"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/38.3.202","article-title":"Cytokine production by synovial T cells in rheumatoid arthritis","volume":"38","author":"G Steiner","year":"1999","journal-title":"Rheumatology"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/jir.2011.0094","article-title":"A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis","volume":"31","author":"B Astry","year":"2011","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"BF Boyce","year":"2008","journal-title":"Archives of biochemistry and biophysics"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.rdc.2010.03.003","article-title":"Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention","volume":"36","author":"S Karmakar","year":"2010","journal-title":"Rheumatic diseases clinics of North America"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"S Kotake","year":"1999","journal-title":"The Journal of clinical investigation"},{"issue":"1\u20132","key":"ref9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10354-005-0244-7","article-title":"Rheumatoid arthritis: inflammation and bone loss","volume":"156","author":"G Schett","year":"2006","journal-title":"Wiener medizinische Wochenschrift"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1007\/s00296-011-2175-5","article-title":"Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis","volume":"32","author":"S Xu","year":"2012","journal-title":"Rheumatology international"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"EM Gravallese","year":"2000","journal-title":"Arthritis and rheumatism"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10067-009-1207-y","article-title":"Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year","volume":"28","author":"JE Fonseca","year":"2009","journal-title":"Clinical rheumatology"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","article-title":"IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation","volume":"163","author":"LA Joosten","year":"1999","journal-title":"Journal of immunology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/art.20982","article-title":"Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study","volume":"52","author":"JS Smolen","year":"2005","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"JA Singh","year":"2012","journal-title":"Arthritis care & research"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.12703\/P6-31","article-title":"Advances in the treatment of rheumatoid arthritis","volume":"6","author":"N Vivar","year":"2014","journal-title":"F1000prime reports"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.autrev.2012.02.022","article-title":"Effective treatment of rat adjuvant-induced arthritis by celastrol","volume":"11","author":"R Cascao","year":"2012","journal-title":"Autoimmunity reviews"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar3168","article-title":"Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis","volume":"12","author":"R Cascao","year":"2010","journal-title":"Arthritis research & therapy"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jep.2008.05.028","article-title":"Therapeutic effect of tripterine on adjuvant arthritis in rats","volume":"118","author":"H Li","year":"2008","journal-title":"Journal of ethnopharmacology"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.bmc.2012.06.050","article-title":"Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines","volume":"20","author":"SH Venkatesha","year":"2012","journal-title":"Bioorganic & medicinal chemistry"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"e35733","DOI":"10.1371\/journal.pone.0035733","article-title":"Development of B cells and erythrocytes is specifically impaired by the drug celastrol in mice","volume":"7","author":"S Kusy","year":"2012","journal-title":"PloS one"},{"issue":"26","key":"ref22","doi-asserted-by":"crossref","first-page":"22216","DOI":"10.1074\/jbc.M112.356816","article-title":"Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk","volume":"287","author":"SM Nanjundaiah","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/art.20664","article-title":"Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis","volume":"50","author":"DM Gerlag","year":"2004","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.53.5.315","article-title":"Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane","volume":"53","author":"G Yanni","year":"1994","journal-title":"Annals of the rheumatic diseases"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/40.4.367","article-title":"Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies","volume":"40","author":"MD Smith","year":"2001","journal-title":"Rheumatology"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","article-title":"Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis","volume":"37","author":"RJ Dolhain","year":"1998","journal-title":"British journal of rheumatology"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D","article-title":"Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers","volume":"43","author":"MC Kraan","year":"2000","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/art.11098","article-title":"Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue","volume":"48","author":"TJ Smeets","year":"2003","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis","volume":"43","author":"PC Taylor","year":"2000","journal-title":"Arthritis and rheumatism"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/ard.2007.080960","article-title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response","volume":"67","author":"RM Thurlings","year":"2008","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/40.1.62","article-title":"The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis","volume":"40","author":"G Cunnane","year":"2001","journal-title":"Rheumatology"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3899\/jrheum.090348","article-title":"Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers","volume":"36","author":"B Bresnihan","year":"2009","journal-title":"The Journal of rheumatology"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"JJ Haringman","year":"2006","journal-title":"Arthritis and rheumatism"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1002\/art.22964","article-title":"Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker","volume":"56","author":"CA Wijbrandts","year":"2007","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","article-title":"Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis","volume":"64","author":"JJ Haringman","year":"2005","journal-title":"Annals of the rheumatic diseases"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/art.34649","article-title":"JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production","volume":"64","author":"TP LaBranche","year":"2012","journal-title":"Arthritis and rheumatism"},{"issue":"7\u20138","key":"ref37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2012.07.003","article-title":"Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance","volume":"91","author":"HY Kim","year":"2012","journal-title":"Life sciences"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.intimp.2010.08.022","article-title":"(Z)-5-(4-methoxybenzylidene) thiazolidine-2, 4-dione ameliorates the adjuvant-induced arthritis via inhibiting the migration of macrophage and down-regulating the cytokine mRNA expression","volume":"10","author":"Y Ma","year":"2010","journal-title":"International immunopharmacology"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/hum.2009.217","article-title":"Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy","volume":"22","author":"SY Chen","year":"2011","journal-title":"Human gene therapy"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2877","article-title":"A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis","volume":"11","author":"B Le Goff","year":"2009","journal-title":"Arthritis research & therapy"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jep.2012.09.005","article-title":"Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats","volume":"144","author":"J Zhang","year":"2012","journal-title":"Journal of ethnopharmacology"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10875-008-9238-8","article-title":"The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis","volume":"29","author":"M Stolina","year":"2009","journal-title":"J Clin Immunol"},{"issue":"1","key":"ref43","first-page":"43","article-title":"Reinnervation of post-arthritic joints in the rat","volume":"14","author":"JA da Silva","year":"1996","journal-title":"Clinical and experimental rheumatology"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"R825","DOI":"10.1186\/ar1751","article-title":"Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens","volume":"7","author":"T Tsubaki","year":"2005","journal-title":"Arthritis research & therapy"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.20382","article-title":"Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis","volume":"50","author":"NA Sims","year":"2004","journal-title":"Arthritis and rheumatism"},{"issue":"4\u20135","key":"ref46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0940-2993(11)80121-1","article-title":"Different immunological mechanisms contribute to cartilage destruction in antigen-induced arthritis","volume":"46","author":"R Brauer","year":"1994","journal-title":"Experimental and toxicologic pathology: official journal of the Gesellschaft fur Toxikologische Pathologie"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M","article-title":"Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis","volume":"43","author":"AM Bendele","year":"2000","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"e0117100","DOI":"10.1371\/journal.pone.0117100","article-title":"Arthritis induces early bone high turnover, structural degradation and mechanical weakness","volume":"10","author":"B Vidal","year":"2015","journal-title":"PloS one"},{"issue":"Pt A","key":"ref49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jep.2014.10.021","article-title":"Evaluation of the efficacy and safety of different Tripterygium preparations on collagen-induced arthritis in rats","volume":"158","author":"X Zhu","year":"2014","journal-title":"Journal of ethnopharmacology"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.163.6.1363","article-title":"Tumor necrosis factor\/cachectin interacts with endothelial cell receptors to induce release of interleukin 1","volume":"163","author":"PP Nawroth","year":"1986","journal-title":"The Journal of experimental medicine"},{"issue":"17","key":"ref51","doi-asserted-by":"crossref","first-page":"15138","DOI":"10.1074\/jbc.M111.226365","article-title":"Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses","volume":"286","author":"SH Venkatesha","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.clim.2015.01.011","article-title":"Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ","volume":"157","author":"B Astry","year":"2015","journal-title":"Clinical immunology"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1096\/fj.10-164095","article-title":"Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo","volume":"24","author":"AI Idris","year":"2010","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.intimp.2014.12.012","article-title":"Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7","volume":"24","author":"K Gan","year":"2015","journal-title":"International immunopharmacology"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"e68905","DOI":"10.1371\/journal.pone.0068905","article-title":"Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4\/NF-kappaB-mediated matrix metalloproteinase-9 expression","volume":"8","author":"G Li","year":"2013","journal-title":"PloS one"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1874312901105010115","article-title":"Synovial tissue response to treatment in rheumatoid arthritis","volume":"5","author":"E Vieira-Sousa","year":"2011","journal-title":"The open rheumatology journal"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/art.10207","article-title":"Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments","volume":"46","author":"JE Fonseca","year":"2002","journal-title":"Arthritis and rheumatism"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.intimp.2012.08.016","article-title":"Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression","volume":"14","author":"GQ Li","year":"2012","journal-title":"International immunopharmacology"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cyto.2010.03.017","article-title":"IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression","volume":"51","author":"M Suzuki","year":"2010","journal-title":"Cytokine"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","article-title":"Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor","volume":"34","author":"M Mihara","year":"1995","journal-title":"British journal of rheumatology"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"M Romano","year":"1997","journal-title":"Immunity"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bcp.2006.08.014","article-title":"Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid","volume":"72","author":"JH Lee","year":"2006","journal-title":"Biochemical pharmacology"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar1958","article-title":"Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation","volume":"8","author":"SW Tas","year":"2006","journal-title":"Arthritis research & therapy"},{"issue":"11","key":"ref64","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8","article-title":"Nuclear factor kappaB\/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts","volume":"41","author":"MP Vincenti","year":"1998","journal-title":"Arthritis and rheumatism"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.intimp.2012.05.015","article-title":"Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol","volume":"13","author":"H Yu","year":"2012","journal-title":"International immunopharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T03:58:16Z","timestamp":1692158296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142448"}},"subtitle":[],"editor":[{"given":"Lisa F.P.","family":"Ng","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":65,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142448","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}